FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2417006502> ?p ?o ?g. }

• W2417006502 endingPage "794" @default.
• W2417006502 startingPage "793" @default.
• W2417006502 abstract "European Journal of Human Genetics (2005) 13, 793–797 & 2005 Nature Publishing Group All rights reserved 1018-4813/05 $30.00 www.nature.com/ejhg NEWS AND COMMENTARIES Complex Disease A new vision for age-related macular degeneration Michael B Gorin European Journal of Human Genetics (2005) 13, 793–794. doi:10.1038/sj.ejhg.5201431 Published online 27 April 2005 I n the March 10 issue of Science, three research groups independently reported evidence of a strong asso- ciation of the Tyr402His polymorphism in the complement H factor (CFH) gene with the development of a disease that is the leading cause of untreatable blindness in the elderly. 1 – 3 Age-related macular degeneration (aka: age-related maculopathy) (AMD) affects nearly 1.75 million individuals in the United States alone. 4 As the proportion of the population that is elderly continues to increase, the prevalence of this condi- tion and its impact on the economic and functional well-being of every society will continue to grow. With a prevalence of advanced AMD features in 1.4% of the population over the age of 40 years, which is a prevalence rising to more than 15% for white women over the age of 80 years, it is estimated that by 2020, the number of individuals in the US with AMD will rise to nearly 3 million indivi- duals. Several previous genome-wide scans, all of which used small families, had indi- cated that chromosome 1q31 was one of the several major susceptibility loci for AMD. 5 – 10 The concordance of these pre- vious studies, which were begun nearly 15 years ago, was remarkable given the different definitions of AMD and ap- proaches used in them. So, these linkage studies provided both the rationale and the focus for the new studies. The first of the Science studies 3 began with a de novo genome-wide scan of more than 116 000 SNPs that used a case – control cohort followed by more inten- sive, high-density SNP genotyping, whereas the other two studies 1,2 relied upon the earlier linkage studies to focus their search for SNP associations. The work of Hoh and colleagues 3 is only the second published instance of such a genome-wide association study. Despite the relative small sample sizes and the potential for confounding of ascertainment bias and mismatching of the cases and controls, all three studies found no significant population stratifica- tion and reached the same conclusions. Surprisingly, all three groups found com- parable levels of risk attributable to the heterozygous and homozygous high-risk ‘C’ alleles (which have His at position 402 of the CFH protein), as well as similar levels of population-attributable risk of the CFH gene for AMD. Haines and colleagues used families as well as case – controls, while the studies by Edwards and colleagues and Klein and colleagues used only case – control designs. As the studies relied upon case – control designs, which select individuals based on their clinical outcomes and not their exposures, they can only provide odds risk ratios, rather than relative risk values. For a common disease such as AMD, these odds ratios may overestimate the extent to which this gene confers risk for AMD. However, there is no doubt that the polymorphism in the CFH gene is respon- sible for the linkage signals that have been observed on chromosome 1 and is a significant factor for the pathogenesis of AMD. In comparison to previous family-based studies, the case – control component of these studies adds a new dimension to the analysis of susceptibility to AMD. In the Edwards et al study, the initial AMD group had a family history for 46.7% of cases, while the replicate AMD sample had only an 18.8% positive family history. No information regarding family history of AMD was provided for the case – control groups in the other two studies. However, these case – control studies, which consid- er AMD cases based on phenotype, ir- respective of a family history, provide strong evidence that the contribution to AMD by the high-risk C allele in the CFH gene extends to both familial and sporadic cases. Specifically, they establish that the susceptibility loci identified in AMD families are also relevant to the general population of AMD patients, irrespective of their family history. These new studies clearly demonstrate the association of the Tyr402His variant in the CFH gene with AMD. However, estab- lishing that the C allele actually causes AMD in individuals who have it is perhaps a more challenging task. 11 Hill 12 provided some of the clearest criteria that can be applied for disease causality and, in this instance, CFH appears to satisfy most of those requirements. In particular, the association is strong, consistent, specific, relatively unbiased, and biologically plau- sible. In addition, there is evidence of a biological gradient and coherence with previous knowledge, and experimental evidence. The biological rationale for CFH comes primarily from studies by Hageman and Anderson, 13 – 16 who have reported the presence of complement factors within the basement membrane and drusen that are typically seen in AMD eyes. There is also ancillary evidence that CFH muta- tions can lead to Type II glomerulone- phritis 17 – 19 (which is associated with AMD-like changes 20,21 ), and that CFH activity is affected by zinc concentration, and is associated with elevated C-reactive protein levels. These ancillary findings provide a rationale for unifying the role of CFH and previous clinical observa- tions, but they are only suggestive at this time. These studies offer a glimpse of the first gene for AMD that can arguably account" @default.
• W2417006502 created "2016-06-24" @default.
• W2417006502 creator A5023709557 @default.
• W2417006502 date "2005-04-27" @default.
• W2417006502 modified "2023-10-12" @default.
• W2417006502 title "Complex Disease: A new vision for age-related macular degeneration" @default.
• W2417006502 cites W1487528435 @default.
• W2417006502 cites W1964523145 @default.
• W2417006502 cites W1965404473 @default.
• W2417006502 cites W1966318341 @default.
• W2417006502 cites W1967253078 @default.
• W2417006502 cites W1980344266 @default.
• W2417006502 cites W2000399151 @default.
• W2417006502 cites W2005511088 @default.
• W2417006502 cites W2022763040 @default.
• W2417006502 cites W2024729125 @default.
• W2417006502 cites W2027707278 @default.
• W2417006502 cites W2047282046 @default.
• W2417006502 cites W2050580170 @default.
• W2417006502 cites W2060170269 @default.
• W2417006502 cites W2068718302 @default.
• W2417006502 cites W2108050710 @default.
• W2417006502 cites W2113784410 @default.
• W2417006502 cites W2117386992 @default.
• W2417006502 cites W2130683634 @default.
• W2417006502 cites W2158981826 @default.
• W2417006502 cites W2168511422 @default.
• W2417006502 cites W3145351529 @default.
• W2417006502 doi "https://doi.org/10.1038/sj.ejhg.5201431" @default.
• W2417006502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15856069" @default.
• W2417006502 hasPublicationYear "2005" @default.
• W2417006502 type Work @default.
• W2417006502 sameAs 2417006502 @default.
• W2417006502 citedByCount "7" @default.
• W2417006502 countsByYear W24170065022012 @default.
• W2417006502 countsByYear W24170065022014 @default.
• W2417006502 countsByYear W24170065022017 @default.
• W2417006502 crossrefType "journal-article" @default.
• W2417006502 hasAuthorship W2417006502A5023709557 @default.
• W2417006502 hasBestOaLocation W24170065022 @default.
• W2417006502 hasConcept C118487528 @default.
• W2417006502 hasConcept C119767625 @default.
• W2417006502 hasConcept C142724271 @default.
• W2417006502 hasConcept C2776403814 @default.
• W2417006502 hasConcept C2779134260 @default.
• W2417006502 hasConcept C2779354088 @default.
• W2417006502 hasConcept C54355233 @default.
• W2417006502 hasConcept C71924100 @default.
• W2417006502 hasConcept C86803240 @default.
• W2417006502 hasConceptScore W2417006502C118487528 @default.
• W2417006502 hasConceptScore W2417006502C119767625 @default.
• W2417006502 hasConceptScore W2417006502C142724271 @default.
• W2417006502 hasConceptScore W2417006502C2776403814 @default.
• W2417006502 hasConceptScore W2417006502C2779134260 @default.
• W2417006502 hasConceptScore W2417006502C2779354088 @default.
• W2417006502 hasConceptScore W2417006502C54355233 @default.
• W2417006502 hasConceptScore W2417006502C71924100 @default.
• W2417006502 hasConceptScore W2417006502C86803240 @default.
• W2417006502 hasIssue "7" @default.
• W2417006502 hasLocation W24170065021 @default.
• W2417006502 hasLocation W24170065022 @default.
• W2417006502 hasOpenAccess W2417006502 @default.
• W2417006502 hasPrimaryLocation W24170065021 @default.
• W2417006502 hasRelatedWork W1021594047 @default.
• W2417006502 hasRelatedWork W1145802917 @default.
• W2417006502 hasRelatedWork W1198741380 @default.
• W2417006502 hasRelatedWork W1425672236 @default.
• W2417006502 hasRelatedWork W2027517098 @default.
• W2417006502 hasRelatedWork W2992755845 @default.
• W2417006502 hasRelatedWork W4206927669 @default.
• W2417006502 hasRelatedWork W766991852 @default.
• W2417006502 hasRelatedWork W935857850 @default.
• W2417006502 hasRelatedWork W1760024223 @default.
• W2417006502 hasVolume "13" @default.
• W2417006502 isParatext "false" @default.
• W2417006502 isRetracted "false" @default.
• W2417006502 magId "2417006502" @default.
• W2417006502 workType "article" @default.